Added to YB: 2026-05-20
Pitch date: 2026-03-13
MEDP [bullish]
Medpace Holdings, Inc.
-7.82%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
N/A
Pitch Price
$455.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
17.89
P/E
N/A
EV/Sales
N/A
Sector
Life Sciences Tools and Services
Category
growth
Medpace Holdings, Inc. - $MEDP
MEDP: CRO specializing in small/mid-cap biotech (95% rev) & FSO model. 20% rev CAGR 2019-25 from ~10%/yr TAM growth + share gains (5%→8%). ~21x ex-cash 2026E EPS for 20%+ EPS growth potential. 5yr algo: 15%+ rev growth + margin expansion + buybacks. August (69, 20% owner) strong capital allocator. AI likely tailwind (accelerates drug pipeline) vs headwind (core expertise insulated). Risks: funding cycles, key man, AI disruption unclear
Read full article (12 min)